Through enhanced diagnostic, disease prevention and tailored treatments, personalized healthcare holds great promise for each of us. Research in this field was long hindered by technical, interoperability, ethical and legal challenges, which prevented access to a wealth of consented biomedical data from patients. SIB has played a key role in coordinating efforts on the national level, and establishing the Swiss infrastructure which is now boosting research in this field, in which over 20 of our groups are active. We are also part of several European public-private partnerships, several of which aiming to facilitate precision medicine in cancer or diabetes. Through outreach activities, we also inform the public about the promise and challenges of precision medicine and the role of bioinformatics to enable it.
Making sense of health data to guide treatment decisions
A new identity to celebrate SIB’s 25 years and the future of life science data
In 25 years, SIB has grown from a handful of visionary scientists to a...
The Swiss Personalized Health Network (SPHN): solutions for researchers
From biomedical project planning to health data recruitment, from data transfer...
In silico talk
Predicting clinical antimicrobial resistance
Antimicrobial resistance was named one of the top ten public health threats to...
Discover SIB in five benefits for society
Have you ever wondered how bioinformatics contributes to health and biodiversity...
The national infrastructure to boost personalized health research is up and running
Connecting researchers from across Switzerland with biomedical data to foster...
How genomic deletions and duplications affect our health
While most of the human genome is the same across individuals, genomic mishaps...
One entry-point to query them all: the SPHN Federated Query System is online
For the first time, biomedical researchers can assess the availability of...